A Nuneaton hospital is the first in the country to introduce US-designed product across all of its wards.
The PUREWICK® is a new female external catheter that can help reduce the risk of infection by sitting outside the bladder rather than fully catheterising the patient, or using other incontinence aids. George Eliot Hospital in North Warwickshire is the first in the UK to introduce the product hospital wide.
PUREWICK® has the advantages that it works while the patient is lying on her back, on her side or seated. It does not need glue, tape or straps to fit, and the urine is not stored close to the body, helping to prevent sore skin and infection.
George Eliot Hospital in Nuneaton worked in conjunction with medical technology company, BD (Becton, Dickinson and Company, formerly C R Bard), to trial the catheter in three clinical areas. Evaluation was carried out in December 2018 and February 2019 and the results were so successful that the catheters are now in use across the hospital.
“George Eliot Hospital is the first UK hospital to implement this product across the whole Trust, enabling the availability of a non-invasive option for our female patients to deal with incontinence and the associated risks,” said June Ayre, the George Eliot Hospital’s infection prevention lead nurse.
“This product can be used for stroke patients, immobile patients and those at a high risk of urinary tract infections or tissue damage, partially or fully immobile patients, where an indwelling catheter is not or no longer required.
“This has been a team approach between the infection prevention and control team and BD, as well as the hospital’s tissue viability team, procurement and ward staff. They have all worked together to evaluate this new pioneering product, which has now been fully implemented.”